Skip to main content

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

Volume 16, Number 36, December 2009

Articles

Role of the Transglutaminase Enzymes in the Nervous System and their Possible Involvement in Neurodegenerative Diseases
pp. 4767-4773(7)
Authors: De Vivo, G.; Di Lorenzo, R.; Ricotta, M.; Gentile, V.

Favourites:
ADD

Mepolizumab and Eosinophil-Mediated Disease
pp. 4774-4778(5)
Author: Walsh, G. M.

Favourites:
ADD

Peptide-Based Anticancer Vaccines: Recent Advances and Future Perspectives
pp. 4779-4796(18)
Authors: Mocellin, S.; Pilati, P.; Nitti, D.

Favourites:
ADD

Overview of Naphthalimide Analogs as Anticancer Agents
pp. 4797-4813(17)
Authors: Lv, Min; Xu, Hui

Favourites:
ADD

The Potential of Embryonic Stem Cells Combined with -omics Technologies as Model Systems for Toxicology
pp. 4814-4827(14)
Authors: Winkler, J.; Sotiriadou, I.; Chen, S.; Hescheler, J.; Sachinidis, A.

Favourites:
ADD

Syntheses, Transformations and Pharmaceutical Applications of Kynurenic Acid Derivatives
pp. 4828-4842(15)
Authors: Fulop, F.; Szatmari, I.; Vamos, E.; Zadori, D.; Toldi, J.; Vecsei, L.

Favourites:
ADD

Monoclonal Antibodies in the Treatment of Multiple Sclerosis
pp. 4858-4868(11)
Authors: Pauli, F. D.; Berger, T.; Reindl, M.

Favourites:
ADD

Recent Research in Selective Cyclin-Dependent Kinase 4 Inhibitors for Anti-Cancer Treatment
pp. 4869-4888(20)
Authors: Liu, Ning; Fang, Hao; Li, Yanling; Xu, Wenfang

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more